ARVN analyst estimates
Arvinas (ARVN) analyst ratings, the average price target and its range, and every firm's latest call.
ARVN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 4, 2026 | H.C. Wainwright | Arvinas Inc. (ARVN) PT Lowered to $13 at H.C. Wainwright | $13.00 |
| Aug 10, 2026 | Evercore ISI | Arvinas price target lowered to $14 from $19 at Evercore ISI | $14.00 |
| Aug 10, 2026 | Morgan Stanley | Arvinas price target lowered to $10 from $11 at Morgan Stanley | $10.00 |
| Aug 5, 2026 | Wedbush | Arvinas price target raised to $12 from $11 at Wedbush | $12.00 |
| Aug 4, 2026 | Wells Fargo | Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027 | $11.00 |
| May 13, 2026 | Barclays | Arvinas price target raised to $20 from $18 at Barclays | $20.00 |
| May 13, 2026 | BTIG | Arvinas price target raised to $18 from $16 at BTIG | $18.00 |
| Mar 18, 2026 | Truist Financial | Truist Securities Reiterates Hold Rating on Arvinas Inc. (ARVN) amid positive Parkinson's data | $10.00 |
| Feb 24, 2026 | Wedbush | Arvinas price target raised to $11 from $9 at Wedbush | $11.00 |
| Dec 17, 2025 | Barclays | Arvinas price target raised to $18 from $16 at Barclays | $18.00 |
| Oct 30, 2025 | BTIG | Arvinas Inc. (ARVN) PT Raised to $14 at BTIG | $14.00 |
| Oct 15, 2025 | Goldman Sachs | Arvinas downgraded to Sell from Neutral at Goldman Sachs | $6.00 |
| Oct 7, 2025 | Piper Sandler | Arvinas price target raised to $16 from $14 at Piper Sandler | $16.00 |
| Sep 18, 2025 | Stephens | Arvinas price target lowered to $14 from $16 at Stephens | $14.00 |
| Sep 18, 2025 | BTIG | Arvinas price target lowered to $10 from $16 at BTIG | $10.00 |
- 9 firms rate ARVN: 7 buy, 2 hold, 0 sell.
- The average price target is $12.00 from None analysts, from $10.00 to $14.00.
Updated 2026-11-18 05:48 UTC